繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

HUT,CXAI和BDRX在市场前的输家中

2024-04-02 20:37

  • Losers: Acorda Therapeutics (ACOR-76% as it files for Chapter 11 bankruptcy.
  • Gritstone Bio (GRTS-43% on prices $32.5M equity offering.
  • Verve Therapeutics (VERV-36% after pausing trial enrollments for lead asset.
  • Canoo (GOEV-29% reports mixed Q4 results.
  • PVH Corp (PVH-23% after Q4 earnings release.
  • Avalo Therapeutics (AVTX) -20% appoints Biotech leaders to board of directors.
  • Pioneer Power Solutions (PPSI-19% after Q4 earnings release.
  • Petros Pharmaceuticals (PTPI) -19%.
  • Imuno (IMNN) -13%.
  • CXApp (CXAI) -14%.
  • Terran Orbital Corp (LLAP-12% after Q4 earnings release.
  • Xilio Therapeutics (XLO-12% reports Q4 results.
  • AST SpaceMobile (ASTS-11% after FY earnings release.
  • Humana (HUM) -10%.
  • Biodexa Pharmaceuticals Plc (BDRX) -10%.
  • Hut 8 Corp (HUT) -9%.
  • iBio (IBIO) -9%.
  • Allego NV (ALLG) -9% to postpone fourth quarter and full year 2023 financial results conference call.
  • Ocugen (OCGN) -8% provides business update with certain financials for the year ending 2023.
  • Petco Health and Wellness Co (WOOF-8% after double downgrade from BofA.
  • Griid Infrastructure (OTCPK:GRDI) -7%.
  • Lytus Technologies Holdings PTV Ltd (LYT) -8%.
  • Cipher Mining (CIFR-7% bitcoin production slips 5% M/M in March.
  • Microstrategy (MSTR) -7%.
  • Argo Blockchain Plc (ARBK) -7%.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。